Camonsertib in DNA damage response-deficient advanced solid tumors: phase 1 trial results - Nature Medicine

Österreich Nachrichten Nachrichten

Camonsertib in DNA damage response-deficient advanced solid tumors: phase 1 trial results - Nature Medicine
Österreich Neuesten Nachrichten,Österreich Schlagzeilen
  • 📰 NatureMedicine
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 53%

The oral ATR kinase inhibitor camonsertib is well tolerated in patients with DNA damage response-deficient SolidTumors and displays encouraging anti-tumor activity, with the highest response rate in patients with OvarianCancer.

T.A.Y.

has received grants or contracts paid to their institution from Merck, AstraZeneca, Regeneron, Roche, Repare Therapeutics, GlaxoSmithKline and Seagen; consulting fees from Novocure, Merck, AstraZeneca, GlaxoSmithKline, Eisai and Shattuck Labs; payment or honoraria for lectures, presentations, speaker’s bureaus, manuscript writing or educational events from AstraZeneca, GlaxoSmithKline and Eisai/Merck; and participation on a data safety monitoring board or advisory board from AstraZeneca. N.B.M.

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

NatureMedicine /  🏆 451. in US

Österreich Neuesten Nachrichten, Österreich Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

Stanford Medicine Reveals: Tiny DNA Circles Defying Genetic Laws Drive Cancer FormationStanford Medicine Reveals: Tiny DNA Circles Defying Genetic Laws Drive Cancer FormationTiny circles of DNA harbor cancer-associated oncogenes and immunomodulatory genes promoting cancer development. They arise during the transformation from pre-cancer to cancer, say Stanford Medicine-led team. Tiny circles of DNA that defy the accepted laws of genetics are key drivers of cancer for
Weiterlesen »

Inside the nascent industry of AI-designed drugs - Nature MedicineInside the nascent industry of AI-designed drugs - Nature MedicineArtificial intelligence tools are beginning to upend the drug discovery pipeline, with several new compounds entering clinical trials.
Weiterlesen »

Researchers and regulators plan for a future without lab animals - Nature MedicineResearchers and regulators plan for a future without lab animals - Nature MedicineThe US Food and Drug Administration has reduced requirements for preclinical animal testing, leading to a surge of interest in organoids, tissue chips and in silico testing.
Weiterlesen »

Research software engineering accelerates the translation of biomedical research for health - Nature MedicineResearch software engineering accelerates the translation of biomedical research for health - Nature MedicineResearch software engineering accelerates the translation of biomedical research for health. Comment from Dave_Horsfall Muzz_Haniffa and colleagues sangerinstitute
Weiterlesen »

‘MacGyver med’ and rock-and-roll: Event medicine is the ticket for some‘MacGyver med’ and rock-and-roll: Event medicine is the ticket for someLarge-event medical services started becoming more formalized about 20 years ago. From Coachella to the Preakness to Lollapalooza, these doctors see it all: blue patients, drunken falls and overheated dancers.
Weiterlesen »

DNA Test Proves Ex-Wrestler Not Lauren Boebert’s FatherDNA Test Proves Ex-Wrestler Not Lauren Boebert’s FatherStan Lane has been dogged by accusations that he got the congresswoman’s mother pregnant during a brief affair.
Weiterlesen »



Render Time: 2025-03-12 17:32:56